Tagged: intellectual property rights
Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
India is known as the pharmacy of the world but 65% of Indians have no access to essential medicines. This video explains how the State of Rajasthan in India is tackling the problem by promoting generic medicines and providing these free of charge in the public sector.
On the eve of a high-level summit between the leaders of India and the European Union in Delhi, Oxfam is calling on the EU not to pressure India into agreeing new trade rules that could deny hundreds of millions of people access to affordable medicines.
Contact EU Office
Oxfam International EU Advocacy Office
Rue de la Science 4, 1000 Brussels, Belgium
Tel: +32 2 234 1110 | Fax: +32 2 502 1941
For general enquiries: eu@oxfaminternational.org
For media enquiries: eumedia@oxfaminternational.org

